Add videos to your saved list and come back to them any time.

In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment ...

Medically reviewed by Robert Burakoff, MD Celiac disease is a chronic autoimmune disorder that can damage the lining of your ...

Osteoporosis, a disease that weakens your bones, is also called a “silent” disease because there are no warning signs until a ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Lung transplant patients should undergo annual bone health screenings using dual-energy X-ray absorptiometry for the first ...

An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

The presentation highlights the potential benefits of eneboparatide as a treatment for hypoparathyroidism, an illness in ...

Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.

Entera Bio ( (ENTX) ) just unveiled an announcement. Entera Bio Ltd., a leader in oral peptide development, reported Q3 2024 financial results ...

Because there are typically no symptoms until the first fracture occurs, osteoporosis is considered a silent disease. Some ...